Basal ganglia hemorrhage
Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
Basal ganglia hemorrhages are a common form of intracerebral hemorrhage, and usually result from poorly controlled long-standing hypertension, although they also have other causes. When due to chronic hypertension, the stigmata of chronic hypertensive encephalopathy are often present (see cerebral microhemorrhages).
Basal ganglia hemorrhages are a subset of intracerebral hemorrhage yet account for 65% of spontaneous intracerebral hemorrhages 6.
The presentation will vary widely depending on the patient's medical history and the size of the hemorrhage. There is a strong association between basal ganglia hemorrhage and lacunar syndrome, hematomas involving the posterior capsule will lead to contralateral sensorimotor deficits 7,8. Patients can present with an ipsilateral deviation of the eyes due to descending capsular pathways from the frontal eye field.
Long-standing poorly controlled hypertension accounts for the majority of basal ganglia hemorrhage, and leads to a variety of pathological changes in the vessels:
microaneurysms of perforating arteries (Charcot-Bouchard aneurysms)
small (0.3-0.9 mm) diameter aneurysms that occur on small (0.1-0.3 mm) diameter arteries
a distribution that matches the incidence of hypertensive hemorrhages 5
found in hypertensive patients
may thrombose, leak (see cerebral microhemorrhages) or rupture 2
accelerated atherosclerosis: affects larger vessels
hyperplastic arteriosclerosis: seen in very elevated and protracted cases
Typically a region of hyperdensity is demonstrated centered on the basal ganglia or thalamus. Not infrequently there may be an extension into the ventricles, with occasionally the parenchymal component being very small or inapparent.
If there is no intraventricular extension, the hemorrhage volume may be estimated by ABC/2 and related formulas, which may have neurosurgical and prognostic implications.
There are many predictors of hematoma expansion potentially evident on CT, which are discussed in depth in the main intracerebral hemorrhage article.
The appearance of hemorrhage on MRI varies with time and to some degree the size of the hematoma (see aging blood on MRI).
Treatment and prognosis
The mainstay of treatment is medical, with control of hypertension and attempts to prevent secondary cerebral injury. If an intraventricular component is present then hydrocephalus is a common sequelae and CSF drainage with an extra-ventricular drain is often needed.
Evacuation of the clot is controversial and only potentially useful in large (>60 mL) hemorrhage.
- 1. Schaller B. State-of-the-art imaging in stroke. Nova Biomedical. (2007) ISBN:1600215009. Read it at Google Books - Find it at Amazon
- 2. Warlow C, Dennis MS, Gijn JV et-al. Stroke, a practical guide to management. Wiley. (2001) ISBN:0632054182. Read it at Google Books - Find it at Amazon
- 3. Kumar V, Abbas AK, Fausto N et-al. Robbins and Cotran pathologic basis of disease. W B Saunders Co. (2005) ISBN:0721601871. Read it at Google Books - Find it at Amazon
- 4. Chung CS, Caplan LR, Yamamoto Y et-al. Striatocapsular haemorrhage. Brain. 2000;123 (Pt 9) : 1850-62. Brain (link) - Pubmed citation
- 5. Nelson JS, Mena H, Parisi JE et-al. Principles and Practice of Neuropathology. Oxford University Press, USA. (2003) ISBN:0195125894. Read it at Google Books - Find it at Amazon
- 6. Talacchi A, Ricci U, Caramia G, Massimo G. Basal Ganglia Haemorrhages: Efficacy and Limits of Different Surgical Strategies. Br J Neurosurg. 2010;25(2):235-42. doi:10.3109/02688697.2010.534203 - Pubmed
- 7. An S, Kim T, Yoon B. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017;19(1):3-10. doi:10.5853/jos.2016.00864 - Pubmed
- 8. Arboix A, Comes E, García-Eroles L et al. Site of Bleeding and Early Outcome in Primary Intracerebral Hemorrhage. Acta Neurol Scand. 2002;105(4):282-8. doi:10.1034/j.1600-0404.2002.1o170.x - Pubmed